To determine if MYB protein is preferentially required during specific stages of normal human hematopoiesis we incubated normal marrow mononuclear cells (MNC) with c-myb antisense oligodeoxynucleotides. Treated cells were cultured in semisolid medium under conditions designed to favor the growth of specific progenitor cell types. Compared with untreated controls, granulocyte-macrophage (GM) CFU-derived colonies decreased 77% when driven by recombinant human (rH) IL-3, and 85% when stimulated by rH GM colony-stimulating factor (CSF); erythroid burst-forming unit (BFU-E)-and CFU-E-derived colonies decreased 48 and 78%, respectively. In contrast, numbers of G-CSF-stimulated granulocyte colonies derived from antisense treated MNC were unchanged from controls, though the numbers of cells composing these colonies decreased -90%. Similar results were obtained when MY10' cells were exposed to c-myb antisense oligomers.
Introduction
Normal circulating myeloid and erythroid cells are derived from a small complement of bone marrow progenitors that give rise to these morphologically recognizable elements after a myriad of cell proliferation and maturation events (1, 2). The molecular processes that regulate these events, especially in humans, remain largely unknown because of difficulties in isolating sufficient cellular material with which to conduct such investigations. Based on studies demonstrating that the generation of hematopoietic colonies closely mimics in vivo hematopoiesis (3-5); that a variety ofrecombinant hematopoietic growth factors can be used for the growth of specific progenitor cell types (6, 7); and-that antisense oligodeoxynucleotides can block the activity of specific genes in hematopoietic cells (8) (9) (10) , we have developed a strategy that allows direct assessment of the role of specific genes in regulating hematopoiesis. With this approach we recently showed that exposure of partially purified human hematopoietic progenitor cells to a synthetic oligodeoxynucleotide complementary to c-myb mRNA inhibits human hematopoietic colony formation in vitro (11) . Although those studies provided direct evidence that the c-myb gene product plays an important role in regulating hematopoiesis, the stage of hematopoietic development during which c-myb gene function is most important remained unknown. In particular, it remained unclear whether c-myb function was most relevant for the proliferation of progenitor cells or whether it was needed at an earlier (lineage commitment) or later (precursor differentiation) stage of hematopoietic development. To address these questions, we analyzed the growth of late and early progenitors in vitro after exposure to a c-myb antisense oligomer. Our findings suggest that c-myb gene function is preferentially required for the proliferation of intermediate-late hematopoietic progenitors; is less critical for the proliferation of early progenitors; and may not be required for lineage commitment.
Methods
Cells. Human bone marrow cells were obtained from normal healthy volunteers after informed consent. Light density mononuclear cells (MNC)' were obtained by Ficoll-Hypaque density gradient centrifugation and enriched for hematopoietic progenitors by first removing adherent and phagocytic elements and then T lymphocytes as previously described (12) . MNC depleted of adherent/phagocytic and T cells (A-T-MNC) were then plated in semisolid medium or further enriched for immature progenitors by immunorosetting with anti-HPCA-1 MAb (Becton Dickinson, Mountain View, CA), which recognizes the MY0 or CD34 antigen (13) . Briefly, packed sheep red blood cells (SRBC) were incubated with an equal volume of 0.1% CrC13 and F(ab)2 goat anti-mouse affinity-purified F(ab)2 (1 mg/ml; Cappel Labo-ratories, Cochranville, PA) for 10 min at room temperature. SRBC were then extensively washed in normal saline and resuspended at a concentration of2% in normal saline (200 jAd ofpacked SRBC in a final volume of 10 ml). Marrow cells were incubated for 60 min at 4VC (6 X 106 cells/ml) in the presence of 1:50 anti-HPCA-l MAb. After extensive washing, antibody-treated SRBC (0.4 ml/106 cells) were added to cells, pelleted, and incubated for I h at 4VC. Rosetted cells were then separated on a Ficoll gradient and SRBC were subsequently eliminated with a iysing reagent (Ortho Pharmaceutical, Raritan, NJ).
Colony Oligodeoxynucleotides. Unmodified, 18-base oligodeoxynucleotides were made on a DNA synthesizer (model 380B; Applied Biosystems Inc., Foster City, CA) by means of fl-cyanoethyl-phosphorymidite chemistry. Oligodeoxynucleotides were purified by ethanol precipitation and multiple washes in 70% ethanol. They were subsequently lyophilized to dryness and redissolved in culture medium at a concentration of 1 mg/ml. The sequence of the c-myb antisense oligomer is 5'-GTGCCGGGGTCTTCGGGC-3' and is complementary to 18 nucleotides starting from the second codon of c-myb mRNA (14) ; the c-myb sense oligomer has the sequence 5'-GCCCGAAGACCCCGG-CAC-3'. The sequence of the c-myc antisense oligomer is 5'-GAAGC-TAACGTTGAGGGG-3' and is complementary to 18 nucleotides starting from the second codon ofc-myc mRNA (15 (16) . RNA was then reverse-transcribed using 500 U of Moloney murine leukemia virus reverse transcriptase and 0.2 Mg of oligo(dT) as primer for 1 h at 37°C.
The resulting cDNA fragments were amplified with 7.5 U of Thermus aquaticus (Taq) polymerase in the presence of c-myb mRNA sequence-specific synthetic primers; the 5' oligonucleotide corresponds to the c-myb mRNA sequence from nucleotides 2,258-2,279 and the 3' oligonucleotide corresponds to nucleotides 2,466-2,487. Therefore, a 230-bp fragment corresponding to a portion of the 3' untranslated region of c-myb (14) was generated during 60 cycles of polymerase chain reaction (17) . 10 Ml of the 50-Mi polymerase chain reaction was separated in a 4% Nusieve agarose gel and transferred to a nitrocellulose filter. The resulting blot was hybridized with a synthetic 50-base c-myb oligomer complementary to the amplified c-myb cDNA from nucleotides 2,351-2,400 (14) . The synthetic c-myb oligomer was endlabeled with [32P],y-ATP and polynucleotide kinase as described (18) . (19, 20) .
Results
Effect of sense and antisense myb and myc oligomers on human bone marrow (A-T-MNC). A-T-MNC were exposed to oligomer preparations for 18 h and then cloned in cultures optimized for the growth of specific progenitor cell subsets (see methods). Data relative to erythroid progenitor cell growth are shown in Fig. 1 . Bars express percent of growth of antisensevs. sense-treated cells (assumed as 100%) and are mean±SD of three different experiments. Mean colony yield was 54±2 (2.5 X 104 cells plated) for BFU-E and 298±20 for CFU-E in three different experiments. Sense oligomers gave 2-20% inhibition compared with untreated controls. Treatment with the c-myb antisense oligomer resulted in a 48% decrement in the number of BFU-E colonies, whereas the decrease of CFU-E colonies was 78%, a value consistent with our previous findings (I1). Colony size was also analyzed (Table I ). In the case of BFU-E, median colony size was 12,000 for untreated controls. Sense oligomers gave only a small reduction in the number of cells per colony (10,000 = 16.6% inhibition), whereas antisense oligomers effected a drastic reduction in colony size (1,500 cells per colony = 87.5% inhibition). When erythroid colonies formed in the presence of a c-myc antisense oligomer, no decrement in either colony size or number was noted as compared with control colonies. An analysis of myeloid colony formation in the presence of c-myb and c-myc oligomers is shown in Fig. 2 . Data relative to CFU-granulocyte/macrophage (CFU-GM) growth in the presence of IL-3 or GM-CSF, and G-CSFstimulated CFU-granulocyte (CFU-G) growth are presented. Mean (Fig. 2) . However, analysis of CFU-G colony size (Table I and Fig. 3) Effect of sense and antisense myb and myc oligomers on marrow MYJO+ MNC. To analyze the effect of antisense oligomers on the growth of a more homogeneous, less mature population of progenitors the same set of experiments were performed on marrow cells enriched for MYl0+ MNC. Because neither CFU-E nor CFU-G are contained within this cell population (21) , only day 14 CFU-GM and BFU-E derived colonies were studied. Mean colony yield was 56±3 for BFU-E and 63±6 or 86±4 for CFU-GM, stimulated with IL-3 or GM-CSF, respectively. Little inhibition in the numbers of colonies formed was observed in either the sense-or antisensetreated cultures (Fig. 4) . However, colony size was consistently affected (Table II) . Median colony size for BFU-E formed in presence of c-myb sense oligomer was 15,500 cells/colony. This value was reduced to 4,000 cells/colony (average inhibition 75%) in the presence ofthe c-myb antisense oligomer. Fig.  5 shows representative BFU-E colonies growing in the presence of c-myb sense (B) or c-myb antisense (C) oligomers. CFU-GM colonies were also reduced in size when formed in the presence ofthe c-myb antisense oligomer (median value 55 vs. 700 = 93% inhibition for IL-3-stimulated CFU-GM, and 55 vs. 550 = 90% inhibition for GM-CSF-stimulated CFU-GM). No effect was observed with c-myc sense or antisense oligomers.
Expression ofc-myb mRNA in bone marrow cells exposed to c-myb oligomers. To address the possibility that the differential effect of the c-myb antisense oligodeoxynucleotides on the various progenitor subsets was due to differential cellular uptake of oligomers, equal numbers of MYI0 MNC and A-T-MNC (4 X 104) were exposed to c-myb sense and antisense sequences and analyzed for c-myb mRNA expression by RT-PCR analysis. c-myb mRNA was detected in untreated marrow cells (Fig. 6, lanes A and D) and in cells exposed to c-myb sense oligomer (Fig. 6, lanes B and E) but not in MY10+ MNC or A-T-MNC exposed to a c-myb antisense oligomer (Fig. 6, lanes C and F) . These results suggest that c-myb oligomers are taken up with similar efficiency by the majority of A-T-MNC and MY10+ MNC, since in both cases c-myb mRNA was no longer detectable in the presence of the antisense oligomer.
The disappearance of c-myb mRNA in antisense-treated cultures probably results from c-myb mRNA degradation after the formation of specific DNA-RNA duplexes that may provide a substrate for cellular RNase-H activity (22) ; a specific disappearance of c-myb mRNA has been also observed in peripheral blood T lymphocytes exposed to c-myb antisense oli- godeoxynucle'otides (20) , and disappearance of c-abl transcripts has been observed in K562 cells exposed to c-abl antisense oligodeoxynucleotides (22a).
Detection of c-myb mRNA and c-myb protein during in vitro diferentiation ofMY]0+ MNC. To follow the expression of c-myb mRNA during the differentiation of marrow MY I0+ MNC, these cells were cultured for different time periods in the presence of IL-3 and GM-CSF, and c-myb mRNA levels were measured by RT-PCR analysis using 1.6 X 105 or 1 X 105 cells. In each experiment 7-8 X I07 marrow cells were used for purification with a final yield of 1-3 X lIO MY10+ MNC enriched elements. Fig. 7 shows a Southern blot of the products of cDNA amplification using a 5' and a 3' c-myb sequence-specific primers hybridized to an end-labeled diagnostic probe 50 bases long corresponding to the amplified c-myb fragment from nucleotides 2,351-2,400 (14) . A 230-bp c-myb amplified fragment is detected in MY10+ MNC at day 0 (Fig.  7, lane A) and after growth in culture in the presence of GM-CSF and IL-3 for 4 and 8 d when c-myb mRNA levels were slightly increased (Fig. 7, lanes B and C) , but not after 14 d in culture (Fig. 7, lane D) ; in a second experiment c-myb mRNA was detected in MY10+ MNC at day 0 (Fig. 7 , lane E) but was no longer detectable at day 14 (Fig. 7, lane F) . This kinetics suggests that c-myb mRNA expression is maximal in actively cycling cultured MY10+ MNC, whereas c-myb mRNA is undetectable when MY I0+ MNC are well advanced in their process of differentiation (not shown). We also analyzed the expression of c-myb protein by immunofluorescence and in agreement with the observations of Kastan et al. (23) detected c-myb protein in marrow MY10+ on day 0, but not after 21 d in culture in the presence of GM-CSF and IL-3 (not shown).
Discussion
Under homeostatic conditions hematopoiesis is maintained by a small subset of pluripotent stem cells and unipotent progenitor cells that reside in the Go phase of the cell cycle. When needed, these cells enter into the cell cycle, synthesize DNA, and divide to generate an amplified population of functionally mature elements. The cloning of the genes for several hematopoietic growth factors and the resulting production of the encoded recombinant proteins have led to major conceptual advances in understanding the regulation of normal hematopoiesis (6). However, the intermediary events that occur distal to the interaction between growth factors and their own receptors and the nuclear processes that specifically regulate proliferation and differentiation during hematopoietic development are still poorly understood (24) . In theory, the activation of nuclear protooncogenes could provide a functional link between events occurring at the cellular membrane and the ensuing proliferative and maturative responses ofthe hematopoietic and other cellular systems (25) . In fact, several studies have provided indirect evidence suggesting the importance of the c-myb nuclear protooncogene in regulating hematopoietic proliferation and differentiation (26) (27) (28) . We recently took a direct approach and reported that a c-myb antisense oligomer inhibits in vitro growth of CFU-E, CFU-GM, and CFU-megakaryocyte colonies from normal bone marrow progenitors depleted of adherent cells and T lymphocytes (1 1). In the present study we analyzed different subsets of human hematopoietic progenitors to ascertain whether inhibition of colony forma-58 MYIO MNC were cultured in semisolid medium under optimal culture conditions for the different subsets tested as described in Methods. After appropriate incubation time (16 d) the colony size was evaluated. For each culture plate the size of 30 consecutive individual colonies was examined as described in Table I . Numbers express the median value observed. The variation range is given in parentheses.
tion by a c-myb antisense oligomer is restricted to a specific level of maturation. Inhibition ofthe proliferation oferythroid progenitors was observed when the target cells analyzed were IS I.
.C. CFU-E and BFU-E derived from bone marrow cells depleted of adherent cells and T lymphocytes. Colony inhibition was most pronounced in CFU-E (22% of that observed in c-myb sense-containing dishes) but was also observed in the growth of BFU-E colonies (52% of c-myb sense-treated dishes). No inhibition of colony number was observed with a subset of more primitive BFU-E derived from the population enriched in the more immature MY I0 progenitors (21), but colony size was much smaller (Table II, Fig. 5 ). Analogous results were obtained from BFU-E grown from peripheral blood (not shown), which is known to contain only the more immature progenitor subsets (29, 30) . Interestingly, the inhibitory effect of the c-myb antisense oligomer is most pronounced in the CFU-E compartment in which 60-80% of the cells are in S phase and virtually all CFU-E are actively progressing through the cell cycle (31) . In contrast, < 30% of the primitive BFU-E are in S phase and at least half of the cells in the BFU-E compartment are not cycling (31) . Since the exposure of BFU-E progenitors to the c-myb antisense oligomer reduced the size of the BFU-E colonies without affecting the total colony number, it is likely that the antisense c-myb oligomer maximally inhibits colony formation once the primitive BFU-E enter into the pool of actively cycling progenitors.
A similar line of reasoning might explain the effects of the c-myb antisense oligomer on the CFU-GM and CFU-G progenitors. The most pronounced effect is on CFU-GM progenitors derived from partially purified marrow cells (-80% growth inhibition), while the effect on the more primitive D) or with c-myb sense (lanes B and E) or c-myb antisense (C and F) oligomers in the presence of IL-3 and GM-CSF. Cells were exposed to oligomers (final concentration 14 M) for 48 h, collected, and total RNA extracted as described (16) . c-myb mRNA was amplified by the RT-PCR technique (17) and detected by hybridizing the products of cDNA amplification with a diagnostic 32P-end-labeled 50-base oligomer corresponding to a region within the amplified c-myb mRNA from nucleotides 2,351-2,400 (14) . CFU-GM progenitors (MY I0+ MNC) is manife,% duction in colony size (Table II) . Analogous resu tained from CFU-GM growth from peripheral shown), which contains only the more immature (30, 32) . Exposure of the more mature CFU-G t antisense oligomer resulted in a significant decrei ony size (Table I) . CFU-G have very high prolifera (50% of the cells in S phase; 29), but the number colony is much higher than that of the analogous tors in the erythroid compartment (CFU-E; Table explain why the antisense myb oligomer reduces rived colony formation while the effect on CFU-G manifested as reduction in colony size.
The differential effect the c-myb antisense o early and late progenitors could have occurred as of differences in cellular uptake of these oligomer their ability to inhibit c-myb function equally in b tor types. The experiment in Fig. 6 suggests that mers are taken up with similar efficiency by the A-T-MNC and MYl0 MNC since in both c mRNA was no longer detectable in the presence sense oligomer. However, the data do not prove ui that c-myb antisense oligodeoxynucleotides eqL c-myb function in the colony-forming progenil compartment, since these cells are a minor A-T-MNC and in MYl0+ MNC. On the other hai of MY10+ MNC to several c-abl antisense oligon in a significant inhibition of CFU-GM colony forn validating the assumption that specific gene func hibited in MYl0+ progenitors exposed to syntheti
We have also noted that exposure of early and itors to c-myc antisense oligodeoxynucleotides d( measurable effects on in vitro hematopoietic color has been shown that the expression of a c-myc at struct introduced by transfection in Friend mur E F leukemia cells accelerates erythroid differentiation in response to a DMSO (33) and that exposure of HL-60 cells to a c-myc antisense oligomer inhibits proliferation and induces terminal differentiation (10) . In contrast, exposure of HL-60 cells to a c-myb antisense oligomer does not induce differentiation (19) . These findings suggest that c-myb and c-myc play different roles in regulating hematopoietic growth and differentiation: downregulation of c-myb expression might directly affect hematopoietic proliferation, whereas low levels of c-myc protein might be necessary to allow hematopoietic cells to enter the differentiation pathway (10, 33) . If downregulation of c-myc expression also accelerates the differentiation of normal marrow progenitors it would be difficult to observe such effect under the standard conditions of colony formation we used.
In summary, our findings suggest that c-myb function is most needed in the compartments containing the highest number of progenitors in S phase, and is less vital to the maintenance of compartments containing earlier 
